Titles on: Accounting & control
Results 451 - 500:
- Electronic Commerce Network (A)
- Elevator Service, Inc.: Testing Internal Controls for Cash Receipts and Disbursement
- Eli Lilly and Co. (A) and (B) (Abridged)
- Eli Lilly and Co. (A)
- Eli Lilly and Co. (B)
- Elmer Kupper
- Elmwood Products, Inc.
- Emergence of an International Accounting Standards Setter
- Empire Blue Cross and Blue Shield (A)
- Empire Blue Cross and Blue Shield (B)
- Empire Blue Cross and Blue Shield (C)
- Empire Blue Cross and Blue Shield (D)
- Empire Blue Cross and Blue Shield (E)
- Empire Blue Cross and Blue Shield (F)
- Empire Blue Cross and Blue Shield (G)
- Empire Blue Cross and Blue Shield (H)
- Empire Glass Co. (A), Spanish Version
- Empire Glass Co. (A)
- Empire Glass Co. (B)
- Ending the Fishing Expedition: The Use of Real-Time MRI in Surgery
- Energy Vending Inc.
- Enron Corp.: May 6, 2001 Sell Recommendation
- Episcopal Retirement Homes, Inc.
- Equity Capital Transactions and Analysis
- Equity Management, Inc.
- Ernst & Young LLP
- Esser & Ackermann at Mannesmann
- Euclid Engineering
- Execution: The Missing Link in Retail Operations
- Executive Pay and the Credit Crisis of 2008 (B)
- Exercise in Fund Accounting: Igertown, Georgia
- Expense Recognition
- Expensing Options Solves Nothing
- Expensing Stock Options: A Fair-Value Approach
- Exploring Statements of Cash Flows
- Extraordinary and Unusual Items, Discontinued Operations, and Accounting Changes
- Extraprise
- Exxon Corp. (A)
- FASB and Employee Stock Options
- FAULKNER HOSPITAL CAPITAL BUDGETING EXERCISE
- FMC Corp.: A Recapitalization (Abridged), Part II
- FMC Corp.: A Recapitalization (Abridged), Part I
- FMC Corp.: A Recapitalization
- Factors That Influence Cross-Border Equity Investment
- Facts and Figures on Defense Procurement: The Department of Defense and Defense Procurement, An Overview
- Fahning Manufacturing Co.
- Fair Value Accounting for Securities and the FASB Process
- Fantasia, SpA
- Farmington Industries, Inc.: Managing Currency Exposure Risk
- Fast Close at Novartis
View Results: [1-50] [51-100] [101-150] [151-200] [201-250] [251-300] [301-350] [351-400] [401-450] [451-500] [501-550] [551-600] [601-650] [651-700] [701-750] [751-800] [801-850] [851-900] [901-950] [951-1000] [1001-1050] [1051-1100] [1101-1150] [1151-1200] [1201-1250] [1251-1300] [1301-1350] [1351-1400] [1401-1450] [1451-1500] [1501-1550] [1551-1590]
 
|
Powered by Content Directions, Inc. (CDI) and the Digital Object Identifier (DOI) View additional CDI examples |